FC
IMUX icon

FORA Capital’s Immunic IMUX Stock Holding History

FORA Capital’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-219
Closed -$27K – 802
2020
Q2 		$27K Buy
+219
New +$22.3K 0.01% 758

Other funds holding IMUX

OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

FORA Capital's IMUX Position: Q3 2020 in Review

FORA Capital sold out of Immunic (IMUX) in Q3 2020, closing a stake of 219 shares — an estimated $27K sold.

FORA Capital first reported a position in IMUX in Q2 2020 and held it in 1 quarter. The position peaked at $27K in Q2 2020. 66 funds tracked by Wall St. Rank hold IMUX as of Q3 2020.

  • FORA Capital reported no remaining Immunic position as of Q3 2020 after selling out during the quarter.
  • FORA Capital sold 219 Immunic shares in Q3 2020, an estimated $27K.
  • FORA Capital first reported a position in Immunic in Q2 2020 and held it in 1 quarter.
  • FORA Capital's Immunic position peaked at $27K in Q2 2020.
  • 66 funds tracked by Wall St. Rank held Immunic as of Q3 2020.

Based on FORA Capital's 13F filing for Q3 2020, filed 13 Nov 2020.